Regencell Bioscience Holdings Limited Net Fee Amt
Regencell Bioscience Holdings Limited (RGC) had Net Fee Amt of $2.76 thousand as of 2025-10-10, per its 424B5 filed 2026-05-19.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-19
- 2025-10-10: Net Fee Amt $2.76K.
| Period end | Net Fee Amt |
|---|---|
| 2025-10-10 | $2.76K 424B5 · filed 2026-05-19 |